We are live on ! Find out more
GIM

Goelzer Investment Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 39.12%
This Fund
S&P 500
This Quarter Est. Return
-3.1%
1 Year Est. Return
+39.12%
3 Year Est. Return
+98.94%
5 Year Est. Return
+113.33%
10 Year Est. Return
+357.99%
AUM
$1.72B
AUM Growth
-$102M
Cap. Flow
-$28.6M
Cap. Flow %
-1.66%
Top 10 Hldgs %
51.02%
Holding
238
New
13
Increased
57
Reduced
134
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 30.08%
2 Technology 10.96%
3 Financials 7.65%
4 Industrials 4.82%
5 Consumer Discretionary 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
51
T. Rowe Price
TROW
$24.3B
$7.29M 0.42%
64,503
+8,638
+15% +$1M
AEP icon
52
American Electric Power
AEP
$66.9B
$7.21M 0.42%
78,187
-1,584
-2% -$153K
PRU icon
53
Prudential Financial
PRU
$42.1B
$7.16M 0.42%
60,407
-1,404
-2% -$173K
BMY icon
54
Bristol-Myers Squibb
BMY
$132B
$7.14M 0.41%
126,307
-4,529
-3% -$253K
PG icon
55
Procter & Gamble
PG
$340B
$6.95M 0.4%
41,452
-1,647
-4% -$281K
GATX icon
56
GATX Corp
GATX
$6.23B
$6.9M 0.4%
44,539
-43
-0.1% -$6.41K
IVW icon
57
iShares S&P 500 Growth ETF
IVW
$77.4B
$6.7M 0.39%
65,977
-5,366
-8% -$535K
ADBE icon
58
Adobe
ADBE
$109B
$6.69M 0.39%
15,038
+2,925
+24% +$1.45M
MDY icon
59
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$6.55M 0.38%
11,491
-162
-1% -$95K
BKNG icon
60
Booking.com
BKNG
$160B
$6.52M 0.38%
32,825
+350
+1% +$67.3K
MCK icon
61
McKesson
MCK
$103B
$6.31M 0.37%
11,071
-288
-3% -$161K
WSM icon
62
Williams-Sonoma
WSM
$29.5B
$6.29M 0.37%
33,977
-772
-2% -$123K
SYY icon
63
Sysco
SYY
$40.1B
$6.26M 0.36%
81,838
-3,280
-4% -$251K
IJK icon
64
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.1B
$6.24M 0.36%
68,671
-3,396
-5% -$320K
TJX icon
65
TJX Companies
TJX
$175B
$6.21M 0.36%
51,418
-457
-0.9% -$54.5K
INGR icon
66
Ingredion
INGR
$6.53B
$6.13M 0.36%
44,562
-1,015
-2% -$143K
LOW icon
67
Lowe's Companies
LOW
$123B
$6.01M 0.35%
24,364
+194
+0.8% +$51.8K
IPG
68
DELISTED
Interpublic Group of Companies
IPG
$5.95M 0.35%
212,451
-5,742
-3% -$171K
SJM icon
69
J.M. Smucker
SJM
$12.6B
$5.9M 0.34%
53,581
-2,304
-4% -$265K
MDT icon
70
Medtronic
MDT
$114B
$5.71M 0.33%
71,441
-1,027
-1% -$88.9K
CAT icon
71
Caterpillar
CAT
$385B
$5.67M 0.33%
15,639
+395
+3% +$153K
APO icon
72
Apollo Global Management
APO
$76B
$5.66M 0.33%
34,287
+305
+0.9% +$48.3K
META icon
73
Meta Platforms (Facebook)
META
$1.52T
$5.64M 0.33%
9,641
+557
+6% +$327K
ACWX icon
74
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
$5.57M 0.32%
106,880
-2,690
-2% -$147K
AZN icon
75
AstraZeneca
AZN
$251B
$5.48M 0.32%
41,845
+11,492
+38% +$1.61M

Similar funds

Goelzer Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Goelzer Investment Management held 238 positions worth $1.72B, down 5.6% from $1.82B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Goelzer Investment Management's Q4 2024 filing shows 13 new, 57 increased, 134 reduced and 3 closed positions. Its largest new stake was Berkshire Hathaway Class A: 6 shares worth $4.09M. The largest sale was State Street SPDR S&P 600 Small Cap Value ETF, an estimated $6.48M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Goelzer Investment Management's largest Q4 2024 buy was Berkshire Hathaway Class A: 6 shares worth $4.09M.
  • Goelzer Investment Management added most to AstraZeneca in Q4 2024, an estimated $1.61M increase.
  • Goelzer Investment Management's biggest Q4 2024 reduction was State Street SPDR S&P 600 Small Cap Value ETF, cutting an estimated $6.48M.
  • Goelzer Investment Management fully exited Xylem in Q4 2024, selling an estimated $539K.
  • Goelzer Investment Management's ten largest holdings make up 51% of its $1.72B portfolio in Q4 2024.
  • Goelzer Investment Management opened 13 new positions and closed 3 in Q4 2024.
  • Goelzer Investment Management's portfolio value fell 5.6% quarter-over-quarter to $1.72B.

Based on Goelzer Investment Management's 13F filing for Q4 2024, filed 21 Jan 2025.